A technique for in vivo mapping of myocardial creatine kinase metabolism

Nature Medicine

Volumn 20, Issue 2, 2014, Pages 209-214

  Haris, Mohammad ^a   Singh, Anup ^a   Cai, Kejia ^a   Kogan, Feliks ^a   McGarvey, Jeremy ^b   Debrosse, Catherine ^a   Zsido, Gerald A ^b   Witschey, Walter R T ^a,b   Koomalsingh, Kevin ^b   Pilla, James J ^b   Chirinos, Julio A ^b,c   Ferrari, Victor A ^b   Gorman, Joseph H ^b   Hariharan, Hari ^a   Gorman, Robert C ^b   Reddy, Ravinder ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE; CREATINE KINASE; HUMANS; MAGNETIC RESONANCE IMAGING; MOLECULAR IMAGING; MUSCLE, SKELETAL; MYOCARDIAL CONTRACTION; MYOCARDIUM; PROTONS; WATER;

EID: 84893778145     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3436     Document Type: Article

References (40)

1. Balaban, R.S., Chesnick, S., Hedges, K., Samaha, F. & Heineman, F.W. Magnetization transfer contrast in MR imaging of the heart. Radiology 180, 671-675 (1991).
2. Bax, J.J., de Roos, A. & van Der Wall, E.E. Assessment of myocardial viability by MRI. J. Magn. Reson. Imaging 10, 418-422 (1999).
3. Kim, H.W., Farzaneh-Far, A. & Kim, R.J. Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. J. Am. Coll. Cardiol. 55, 1-16 (2009).
4. Beek, A.M. et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J. Am. Coll. Cardiol. 42, 895-901 (2003).
5. Schwitter, J. & Arai, A.E. Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance. Eur. Heart J. 32, 799-809 (2011).
6. Kim, R.J. et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N. Engl. J. Med. 343, 1445-1453 (2000).
7. Bax, J.J. et al. Metabolic imaging using F18-fluorodeoxyglucose to assess myocardial viability. Int. J. Card. Imaging 13, 145-155, discussion 157-160 (1997).
8. Kitagawa, K. et al. Acute myocardial infarction: myocardial viability assessment in patients early thereafter comparison of contrast-enhanced MR imaging with resting 201Tl SPECT. Single photon emission computed tomography. Radiology 226, 138-144 (2003).
9. Bonow, R.O. & Dilsizian, V. Thallium 201 for assessment of myocardial viability. Semin. Nucl. Med. 21, 230-241 (1991).
10. Bax, J.J. & Van der Wall, E.E. Assessment of myocardial viability: guide to prognosis and clinical management. Eur. Heart J. 21, 961-963 (2000).
11. Crane, P., Laliberte, R., Heminway, S., Thoolen, M. & Orlandi, C. Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur. J. Nucl. Med. 20, 20-25 (1993).
12. Dzeja, P.P., Redfield, M.M., Burnett, J.C. & Terzic, A. Failing energetics in failing hearts. Curr. Cardiol. Rep. 2, 212-217 (2000).
13. Reimer, K.A., Jennings, R.B. & Tatum, A.H. Pathobiology of acute myocardial ischemia: metabolic, functional and ultrastructural studies. Am. J. Cardiol. 52, 72A-81A (1983).
14. Bottomley, P.A. & Weiss, R.G. Non-invasive magnetic-resonance detection of creatine depletion in non-viable infarcted myocardium. Lancet 351, 714-718 (1998).
15. Beer, M. et al. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with 31P-SLOOP magnetic resonance spectroscopy. J. Am. Coll. Cardiol. 40, 1267-1274 (2002).
16. Neubauer, S. et al. Absolute quantification of high energy phosphate metabolites in normal, hypertrophied and failing human myocardium. MAGMA 11, 73-74 (2000).
17. Nakae, I. et al. Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy. J. Am. Coll. Cardiol. 42, 1587-1593 (2003).
18. Metzler, B. et al. Decreased high-energy phosphate ratios in the myocardium of men with diabetes mellitus type I. J. Cardiovasc. Magn. Reson. 4, 493-502 (2002).
19. Bottomley, P.A., Atalar, E. & Weiss, R.G. Human cardiac high-energy phosphate metabolite concentrations by 1D-resolved NMR spectroscopy. Magn. Reson. Med. 35, 664-670 (1996).
20. Hu, Q. et al. Profound bioenergetic abnormalities in peri-infarct myocardial regions. Am. J. Physiol. Heart Circ. Physiol. 291, H648-H657 (2006).
21. Zhou, J., Payen, J.F., Wilson, D.A., Traystman, R.J. & van Zijl, P.C. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat. Med. 9, 1085-1090 (2003).
22. van Zijl, P.C., Jones, C.K., Ren, J., Malloy, C.R. & Sherry, A.D. MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST). Proc. Natl. Acad. Sci. USA 104, 4359-4364 (2007).
23. Ling, W., Regatte, R.R., Navon, G. & Jerschow, A. Assessment of glycosaminoglycan concentration in vivo by chemical exchange-dependent saturation transfer (gagCEST). Proc. Natl. Acad. Sci. USA 105, 2266-2270 (2008).
24. Gilad, A.A. et al. Artificial reporter gene providing MRI contrast based on proton exchange. Nat. Biotechnol. 25, 217-219 (2007).
25. Haris, M., Cai, K., Singh, A., Hariharan, H. & Reddy, R. In vivo mapping of brain myo-inositol. Neuroimage 54, 2079-2085 (2011).
26. Cai, K. et al. Magnetic resonance imaging of glutamate. Nat. Med. 18, 302-306 (2012).
27. Haris, M. et al. Exchange rates of creatine kinase metabolites: feasibility of imaging creatine by chemical exchange saturation transfer MRI. NMR Biomed. 25, 1305-1309 (2012).
28. Arús, C., Barany, M., Westler, W.M. & Markley, J.L. 1H NMR of intact muscle at 11 T. FEBS Lett. 165, 231-237 (1984).
29. Reijenga, J.C. Comparison of methanol and perchloric acid extraction procedures for analysis of nucleotides by isotachophoresis. J. Chromatogr. A 374, 162-169 (1986).
30. Woo, D.-C. et al. Regional absolute quantification of the neurochemical profile of the canine brain: investigation by proton nuclear magnetic resonance spectroscopy and tissue extraction. Appl. Magn. Reson. 38, 65-74 (2010).
31. Bottomley, P.A. & Weiss, R.G. Noninvasive localized MR quantification of creatine kinase metabolites in normal and infarcted canine myocardium. Radiology 219, 411-418 (2001).
32. Liu, G., Gilad, A.A., Bulte, J.W., van Zijl, P.C. & McMahon, M.T. High-throughput screening of chemical exchange saturation transfer MR contrast agents. Contrast Media Mol. Imaging 5, 162-170 (2010).
33. Laser, A. et al. Regional biochemical remodeling in non-infarcted tissue of rat heart post-myocardial infarction. J. Mol. Cell. Cardiol. 28, 1531-1538 (1996).
34. Bottomley, P.A., Lee, Y. & Weiss, R.G. Total creatine in muscle: imaging and quantification with proton MR spectroscopy. Radiology 204, 403-410 (1997).
35. Francescato, M.P., Cettolo, V. & di Prampero, P.E. Influence of phosphagen concentration on phosphocreatine breakdown kinetics. Data from human gastrocnemius muscle. J. Appl. Physiol. 105, 158-164 (2008).
36. van Vaals, J.J. et al. "Keyhole" method for accelerating imaging of contrast agent uptake. J. Magn. Reson. Imaging 3, 671-675 (1993).
37. Song, H.K. & Dougherty, L. k-space weighted image contrast (KWIC) for contrast manipulation in projection reconstruction MRI. Magn. Reson. Med. 44, 825-832 (2000).
38. Schroeder, M.A. et al. Hyperpolarized magnetic resonance: a novel technique for the in vivo assessment of cardiovascular disease. Circulation 124, 1580-1594 (2011).
39. Lamb, H.J. et al. Metabolic response of normal human myocardium to high-dose atropine-dobutamine stress studied by 31P-MRS. Circulation 96, 2969-2977 (1997).
40. Bottomley, P.A. Spatial localization in NMR spectroscopy in vivo. Ann. NY Acad. Sci. 508, 333-348 (1987).